Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,556 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 603 | $51.35 | $30,964.05 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,806 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,409 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · derivative · entry 9 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · derivative · entry 8 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · derivative · entry 7 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 1,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Tax withholdingCommon Stock | 670 | $50.86 | $34,076.20 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 6 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,208 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 5 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,878 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Tax withholdingCommon Stock | 368 | $50.86 | $18,716.48 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 4 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,628 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,996 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Tax withholdingCommon Stock | 603 | $51.35 | $30,964.05 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,246 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:54 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000004 · wk-form4_1772056473.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,849 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 16:56 UTC |
Hudson Frederick M.Director
|
Disposition to issuerRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438462-26-000004 · wk-form4_1772056609.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,475 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 16:56 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438462-26-000004 · wk-form4_1772056609.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,782 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · derivative · entry 9 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · derivative · entry 8 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · derivative · entry 7 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 1,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,524 | $50.86 | $77,510.64 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 6 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,894 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 5 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,418 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 242 | $50.86 | $12,308.12 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 4 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,418 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,660 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 603 | $51.35 | $30,964.05 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,160 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:22 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000004 · wk-form4_1772058117.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,763 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:36 UTC |
GEMAYEL GEORGESDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001256088-26-000004 · wk-form4_1772055360.xml · derivative · entry 4 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,475 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:36 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001256088-26-000004 · wk-form4_1772055360.xml · nonDerivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,159 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:56 UTC |
Barlow CarroleeDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001745316-26-000004 · wk-form4_1772056565.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,475 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:56 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001745316-26-000004 · wk-form4_1772056565.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,045 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · derivative · entry 9 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · derivative · entry 8 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · derivative · entry 7 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 1,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 646 | $50.86 | $32,855.56 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 6 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,444 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 5 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,090 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 354 | $50.86 | $18,004.44 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 4 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,840 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,194 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 581 | $51.35 | $29,834.35 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,444 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:55 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000004 · wk-form4_1772056527.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,025 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:36 UTC |
GEMAYEL GEORGESDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001256088-26-000004 · wk-form4_1772055360.xml · derivative · entry 3 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:36 UTC |
GEMAYEL GEORGESDirector
|
Exercise / conversionCommon Stock | 15,000 | $12.98 | $194,700.00 |
DisclosureSEC source: 0001256088-26-000004 · wk-form4_1772055360.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:39 UTC |
Sensenig BethanyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001899935-26-000005 · wk-form4_1771882782.xml · derivative · entry 4 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2026. F5 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2026. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:39 UTC |
Sensenig BethanyDirector
|
SaleCommon Stock | 3,258 | $51.27 | $167,037.66 |
DisclosureSEC source: 0001899935-26-000005 · wk-form4_1771882782.xml · nonDerivative · entry 3 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.98 to $51.56. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:39 UTC |
Sensenig BethanyDirector
|
SaleCommon Stock | 1,217 | $50.31 | $61,227.27 |
DisclosureSEC source: 0001899935-26-000005 · wk-form4_1771882782.xml · nonDerivative · entry 2 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,258 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $50.71. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:39 UTC |
Sensenig BethanyDirector
|
Exercise / conversionCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001899935-26-000005 · wk-form4_1771882782.xml · nonDerivative · entry 1 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 16:40 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 4,977 | $0.00 Strike: $50.20 | $0.00 |
DisclosureSEC source: 0001005544-26-000002 · wk-form4_1771623627.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,977 Underlying: Common Stock · 4,977 shares Expires 2036-02-18 F3 · derivative.exercise_date: Each option vests on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 16:40 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantRestricted Stock Unit · Derivative | 2,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001005544-26-000002 · wk-form4_1771623627.xml · derivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,989 Underlying: Common Stock · 2,989 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:47 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000002 · wk-form4_1771624054.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:47 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $50.20 | $0.00 |
DisclosureSEC source: 0001836067-26-000002 · wk-form4_1771624054.xml · derivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2036-02-18 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:46 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantRestricted Stock Unit · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000002 · wk-form4_1771624006.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:46 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $50.20 | $0.00 |
DisclosureSEC source: 0001804567-26-000002 · wk-form4_1771624006.xml · derivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2036-02-18 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 16:39 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 4,977 | $0.00 Strike: $50.20 | $0.00 |
DisclosureSEC source: 0001438462-26-000002 · wk-form4_1771623548.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,977 Underlying: Common Stock · 4,977 shares Expires 2036-02-18 F3 · derivative.exercise_date: Each option vests on February 18, 2027. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 16:39 UTC |
Hudson Frederick M.Director
|
GrantRestricted Stock Unit · Derivative | 2,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001438462-26-000002 · wk-form4_1771623548.xml · derivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,989 Underlying: Common Stock · 2,989 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.